Summary
44 / 100 · Bulios Score
What speaks for it
- It bought back its own shares for 1.44B kr in the last fiscal year, 6.0% of its market value.
What to watch
- The share price is above the Bulios Fair Price.
- It pays out more in dividends than it earns: 109% of profit.
- Out of every 100 DKK of revenue, only 6.8 DKK is left as net profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 26.2 DKK for 1 DKK of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (DKK)
Diluted EPS (DKK)
- Analyst estimate
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
PoorlyWhere 100 DKK of revenue goes
- Cost of sales 0.0 DKK
- Sales and administration 69 DKK
- Taxes and other 3.7 DKK
- Net profit 6.8 DKK
Net profit, industry median (Insurance - Diversified) 8.3 DKK
Out of every 100 DKK of revenue, 6.8 DKK is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Moderate, at risk- Yield
- 4.16%
- Paid out of profit
- 109%
- Raised in a row
- 3 years
You receive $0.21 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Neutral- Buy 0
- Hold 1
- Sell 0
No analyst has published a price target.
0.0% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.